Form 4: Jack W. Schuler Executes Stock Transaction in Accelerate Diagnostics, Inc.
SEC Form 4 Filing
Director Jack W. Schuler reports a transaction involving Accelerate Diagnostics, Inc. stock, including the vesting of restricted stock units.
Summary
- On June 28, 2024, Jack W. Schuler, a director and 10% owner of Accelerate Diagnostics, Inc., executed a transaction involving the company's stock.
- Specifically, 4,737 restricted stock units (RSUs) vested, converting into common stock.
- The reporting person directly owns 20,225 shares of common stock.
- The reporting person indirectly owns 8,510,388 shares through the Jack W. Schuler Living Trust and 5,497 shares through their spouse.
- The RSUs were granted on June 28, 2023, and vest in five equal annual installments beginning on June 28, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders due to the issuance of new shares upon RSU vesting.
Key Dates
| Date | Description |
|---|---|
| 06/28/2023 | Reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024. |
| 06/28/2024 | Vesting of 4,737 Restricted Stock Units (RSUs). |
| 07/01/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.